NEW YORK, July 8 - Jubilant Biosys of Bangalore, India said today that it has licensed its kinase target database to Astex Technology, of Cambridge, UK.
Under the license, Astex will be able to use the database, called the Kinase ChemBioBase, in its structure-based research on lead compounds for drug discovery.
The content in this database is what gives Jubilant a competitive edge, according to Sreeni Devidas, vice president of business development and strategy at Jubilant. The database "has all the relevant information that has never been worked on in kinases," he said, including "over 170,000 compounds and 200,000 structure-activity relationships."
Jubilant provides bioinformatics and chemoinformatics services.